Stellantis shares fell sharply in afternoon trading, dropping 5.1% to $6.68 as investors reacted to a wide-ranging safety recall disclosed the day before and other mounting headwinds.
The company told federal regulators it must recall more than 1.3 million Jeep Wrangler and Gladiator vehicles from the 2021 through 2025 model years because of an electrical defect in the wiring to the hydraulic power steering pump. Stellantis said the defect can lead to fires - including incidents that occurred while the vehicle ignition was off.
In its filing the automaker acknowledged at least 72 fire incidents that may be related to the wiring problem. Crucially, the company does not have a remedy ready and has advised owners to park affected vehicles outdoors and away from structures until a repair is implemented. Stellantis indicated a fix is expected no later than July.
Analyst moves intensified the pressure. On June 9 Citigroup lowered its price target on STLA to 7.20 from 7.50 while maintaining a Neutral rating, citing the operational and safety challenges the automaker faces. The recall adds to a sequence of Jeep-related safety actions and comes amid an ongoing securities class action lawsuit covering investors from early 2025 through early 2026, creating an additional legal overhang for the company.
Broader market dynamics offered little support for shares. Major U.S. indices were in negative territory as investors digested an inflation print and growing geopolitical risk. The S&P 500 was down 0.9%, the Dow Jones Industrial Average declined 1.15%, and the Nasdaq fell 1.17% as the May Consumer Price Index showed annual inflation accelerating to 4.2% - the highest pace in roughly three years. Escalating U.S.-Iran military tensions also pushed oil prices higher and reduced risk appetite across cyclical sectors, including autos.
These combined forces - a high-profile, large-scale recall without an immediate repair, an analyst price-target reduction, persistent litigation exposure, and a risk-off macro backdrop - pressured STLA shares toward their 52-week low of $6.28. The stock traded well below its 52-week high of $12.22, reflecting continued investor skepticism about the speed of the company's turnaround.
Investors face overlapping operational, legal and market uncertainties as the company works toward a remedy expected by July and contends with external economic and geopolitical pressures that are weighing on cyclical sectors.